vs

Side-by-side financial comparison of Day One Biopharmaceuticals, Inc. (DAWN) and SmartRent, Inc. (SMRT). Click either name above to swap in a different company.

Day One Biopharmaceuticals, Inc. is the larger business by last-quarter revenue ($39.8M vs $36.5M, roughly 1.1× SmartRent, Inc.). SmartRent, Inc. runs the higher net margin — -8.9% vs -49.6%, a 40.7% gap on every dollar of revenue. On growth, SmartRent, Inc. posted the faster year-over-year revenue change (3.1% vs -57.6%).

Day One Biopharmaceuticals is a clinical-stage biopharmaceutical firm focused on developing targeted precision oncology therapies for pediatric and young adult patients with genetically driven cancers. It advances novel drug candidates to address unmet medical needs in underserved patient segments, operating primarily in the U.S. and partnering with global oncology research institutions.

Budget Rent a Car System, Inc. is an American car rental company that was founded in 1958 in Los Angeles, California by Morris Mirkin. Budget is a subsidiary of the Avis Budget Group, with its operations headquartered in Parsippany, New Jersey.

DAWN vs SMRT — Head-to-Head

Bigger by revenue
DAWN
DAWN
1.1× larger
DAWN
$39.8M
$36.5M
SMRT
Growing faster (revenue YoY)
SMRT
SMRT
+60.7% gap
SMRT
3.1%
-57.6%
DAWN
Higher net margin
SMRT
SMRT
40.7% more per $
SMRT
-8.9%
-49.6%
DAWN

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
DAWN
DAWN
SMRT
SMRT
Revenue
$39.8M
$36.5M
Net Profit
$-19.7M
$-3.2M
Gross Margin
38.6%
Operating Margin
-60.9%
-10.9%
Net Margin
-49.6%
-8.9%
Revenue YoY
-57.6%
3.1%
Net Profit YoY
-153.3%
71.6%
EPS (diluted)
$-0.19
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DAWN
DAWN
SMRT
SMRT
Q4 25
$36.5M
Q3 25
$39.8M
$36.2M
Q2 25
$33.9M
$38.3M
Q1 25
$30.8M
$41.3M
Q4 24
$35.4M
Q3 24
$93.8M
$40.5M
Q2 24
$48.5M
Q1 24
$0
$50.5M
Net Profit
DAWN
DAWN
SMRT
SMRT
Q4 25
$-3.2M
Q3 25
$-19.7M
$-6.3M
Q2 25
$-30.3M
$-10.9M
Q1 25
$-36.0M
$-40.2M
Q4 24
$-11.4M
Q3 24
$37.0M
$-9.9M
Q2 24
$-4.6M
Q1 24
$-62.4M
$-7.7M
Gross Margin
DAWN
DAWN
SMRT
SMRT
Q4 25
38.6%
Q3 25
26.4%
Q2 25
33.1%
Q1 25
32.8%
Q4 24
28.7%
Q3 24
33.2%
Q2 24
35.7%
Q1 24
38.5%
Operating Margin
DAWN
DAWN
SMRT
SMRT
Q4 25
-10.9%
Q3 25
-60.9%
-19.4%
Q2 25
-103.1%
-30.5%
Q1 25
-133.5%
-99.9%
Q4 24
-36.6%
Q3 24
31.6%
-29.0%
Q2 24
-14.3%
Q1 24
-20.1%
Net Margin
DAWN
DAWN
SMRT
SMRT
Q4 25
-8.9%
Q3 25
-49.6%
-17.3%
Q2 25
-89.4%
-28.3%
Q1 25
-117.0%
-97.2%
Q4 24
-32.3%
Q3 24
39.5%
-24.5%
Q2 24
-9.5%
Q1 24
-15.2%
EPS (diluted)
DAWN
DAWN
SMRT
SMRT
Q4 25
$-0.02
Q3 25
$-0.19
$-0.03
Q2 25
$-0.29
$-0.06
Q1 25
$-0.35
$-0.21
Q4 24
$-0.06
Q3 24
$0.38
$-0.05
Q2 24
$-0.02
Q1 24
$-0.72
$-0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DAWN
DAWN
SMRT
SMRT
Cash + ST InvestmentsLiquidity on hand
$451.6M
$104.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$450.9M
$232.1M
Total Assets
$513.8M
$320.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DAWN
DAWN
SMRT
SMRT
Q4 25
$104.5M
Q3 25
$451.6M
$100.0M
Q2 25
$453.1M
$105.0M
Q1 25
$473.0M
$125.6M
Q4 24
$142.5M
Q3 24
$558.4M
$163.4M
Q2 24
$187.4M
Q1 24
$317.9M
$204.7M
Stockholders' Equity
DAWN
DAWN
SMRT
SMRT
Q4 25
$232.1M
Q3 25
$450.9M
$234.4M
Q2 25
$460.8M
$238.8M
Q1 25
$479.5M
$250.7M
Q4 24
$289.4M
Q3 24
$555.5M
$305.1M
Q2 24
$329.4M
Q1 24
$296.8M
$333.1M
Total Assets
DAWN
DAWN
SMRT
SMRT
Q4 25
$320.9M
Q3 25
$513.8M
$335.8M
Q2 25
$519.0M
$354.0M
Q1 25
$534.4M
$366.1M
Q4 24
$420.2M
Q3 24
$600.8M
$448.6M
Q2 24
$475.3M
Q1 24
$326.6M
$485.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DAWN
DAWN
SMRT
SMRT
Operating Cash FlowLast quarter
$-5.8M
$7.7M
Free Cash FlowOCF − Capex
$7.7M
FCF MarginFCF / Revenue
21.0%
Capex IntensityCapex / Revenue
0.0%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-25.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DAWN
DAWN
SMRT
SMRT
Q4 25
$7.7M
Q3 25
$-5.8M
$-2.1M
Q2 25
$-24.8M
$-14.9M
Q1 25
$-59.0M
$-12.2M
Q4 24
$-12.0M
Q3 24
$50.8M
$-3.7M
Q2 24
$-13.9M
Q1 24
$-49.7M
$-3.3M
Free Cash Flow
DAWN
DAWN
SMRT
SMRT
Q4 25
$7.7M
Q3 25
$-2.2M
Q2 25
$-24.8M
$-16.2M
Q1 25
$-59.3M
$-14.3M
Q4 24
$-13.3M
Q3 24
$50.0M
$-3.9M
Q2 24
$-14.1M
Q1 24
$-3.4M
FCF Margin
DAWN
DAWN
SMRT
SMRT
Q4 25
21.0%
Q3 25
-6.1%
Q2 25
-73.2%
-42.3%
Q1 25
-192.8%
-34.7%
Q4 24
-37.5%
Q3 24
53.4%
-9.7%
Q2 24
-29.1%
Q1 24
-6.7%
Capex Intensity
DAWN
DAWN
SMRT
SMRT
Q4 25
0.0%
Q3 25
0.0%
0.2%
Q2 25
0.0%
3.3%
Q1 25
1.0%
5.3%
Q4 24
3.5%
Q3 24
0.8%
0.6%
Q2 24
0.5%
Q1 24
0.1%
Cash Conversion
DAWN
DAWN
SMRT
SMRT
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
1.37×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DAWN
DAWN

Products$38.5M97%
License Agreement With Ipsen Pharma Sas$1.3M3%

SMRT
SMRT

Hosted Services$18.1M50%
Hardware Service$12.5M34%
Smart Operations Solutions$2.6M7%
Access Control$2.0M5%
Other Smart Communities Solutions$1.3M3%

Related Comparisons